Eli Lilly and Merck’s blockbuster drug sales power earnings ⊕⊕
found
a story from Financial Times ✅ › Financial Times
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Pharma groups boost financial outlooks as revenues from flagship medicines like Zepbound and Keytruda leap